Glycogen Storage Disease - 119 Studies Found
Completed |
: A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II :
|
Completed |
: A Prospective, Observational Study in Patients With Late-Onset Pompe Disease : Glycogen Storage Disease Type II : 2004-02-10 |
Completed |
: A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease : Glycogen Storage Disease Type II : 2003-04-22 : Biological: Myozyme 20 mg/kg qow or 40mg/kg qow Othe |
Active, not recruiting |
: Sodium Valproate for GSDV :
: 2015-08-11 : Drug: Sodium Valproate Subjects will receive sodium valproate modified release 20mg/kg/day (maximum dose |
Completed |
: Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 : Glycogen Storage Disease Type II : 2005-08-01 : Biological: Myozyme 20 mg/kg qow or 40 mg/kg qow Oth |
Recruiting |
: Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies : Glycogen Storage Disease Type III : 2015-05-15 :
|
Recruiting |
: Respiratory Muscle Training in L-Onset Pompe Disease (LOPD) : Glycogen Storage Disease Type II : 2016-06-13 :
|
Recruiting |
: Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT : Glycogen Storage Disease Type II : 2016-04-26 : Other: observation study observation study |
Withdrawn |
: High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease : Glycogen Storage Disease Type II : 2012-08-01 : Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding |